|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts显示文摘BACKGROUND:An updated definition of early allograft dysfunction(EAD) was recently validated in a multicenter study of 300 deceased donor liver transplant recipients.This analysis did not differentiate between donation after brain death(DBD) and donation after cardiac death(DCD) allograft recipients.METHODS:We reviewed our prospectively entered database for all DBD(n=377) and DCD(n=38) liver transplantations between January 1,2006 and October 30,2011.The incidence of EAD as well as its ability to predict graft failure and survival was compared between DBD and DCD groups.RESULTS:EAD was a valid predictor of both graft and patient survival at six months in DBD allograft recipients,but in DCD allograft recipients there was no significant difference in the rate of graft failure in those with EAD(11.5%) compared with those without EAD(16.7%)(P=0.664) or in the rate of death in recipients with EAD(3.8%) compared with those without EAD(8.3%)(P=0.565).The graft failure rate in the first 6 months in those with international normalized ratio ≥1.6 on day 7 who received a DCD allograft was 37.5% compared with 6.7% for those with international normalized ratio <1.6 on day 7(P=0.022).CONCLUSIONS:The recently validated definition of EAD is a valid predictor of patient and graft survival in recipients of DBD allografts.On initial assessment,it does not appear to be a useful predictor of patient and graft survival in recipients of DCD allografts,however a study with a larger sample size of DCD allografts is needed to confirm these findings.The high ALT/AST levels in most recipients of DCD livers as well as the predisposition to biliary complications and early cholestasis make these parameters as poor predictors of graft failure.An alternative definition of EAD that gives greater weight to the INR on day 7 may be more relevant in this population. | Kris P Croome William Wall Douglas Quan Sai Vangala Vivian McAlister Paul Marotta Roberto Hernandez-Alejandro | 2012 | Hepatobiliary & Pancreatic Diseases International2012，11，4： | 15 |
| 2 | Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations显示文摘AIM:To compare the long-term outcome of percutaneous vs surgical radiofrequency ablation(RFA) for hepatocellular carcinoma(HCC) in dangerous locations.METHODS:One hundred and sixty-two patients with HCC in dangerous locations treated with percutaneous or surgical RFA were enrolled in this study.The patients were divided into percutaneous RFA group and surgical RFA group.After the patients were regularly followed up for a long time,their curative rate,hospital stay time,postoperative complications and 5-year local tumor progression were compared and analyzed.RESULTS:No significant difference was observed in curative rate between the two groups(91.3% vs 96.8%,P = 0.841).The hospital stay time was longer and more analgesics were required while the incidence of bile duct injury and RFA-related hemorrhage was lower in surgical RFA group than in percutaneous RFA group(P < 0.05).The local progression rate of HCC in dangerous locations was significantly lower in surgical RFA group than in percutaneous RFA group(P = 0.05).The relative risk of local tumor progression was 14.315 in percutaneous RFA group.CONCLUSION:The incidence of severe postoperative complications and local tumor progression is lower after surgical RFA than after percutaneous RFA. | Ji-Wei Huang Roberto Hernandez-Alejandro Kristopher P Croome Lu-Nan Yan Hong Wu Zhe-Yu Chen Pankaj Prasoon Yong Zeng | 2011 | World Journal of Gastroenterology2011，17，1： | 14 |
| 3 | A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma显示文摘AIM:To compare the clinical outcome and pathologic features of non-alcoholic steatohepatitis(NASH) patients with hepatocellular carcinoma(HCC) and hepatitic C virus(HCV) patients with HCC(another group in which HCC is commonly seen) undergoing liver transplantation.METHODS:Patients transplanted for HCV and NASH at our institution from January 2000 to April 2011 were analyzed.All explanted liver histology and pre-transplant liver biopsies were examined by two specialist liver histopathologists.Patient demographics,disease free survival,explant liver characteristics and HCC features(tumour number,cumulative tumour size,vascular invasion and differentiation) were compared between HCV and NASH liver transplant recipients.RESULTS:A total of 102 patients with NASH and 283 patients with HCV were transplanted.The incidence of HCC in NASH transplant recipients was 16.7%(17/102).The incidence of HCC in HCV transplant recipients was 22.6%(64/283).Patients with NASH-HCC were statistically older than HCV-HCC patients(P < 0.001).A significantly higher proportion of HCV-HCC patients had vascular invasion(23.4% vs 6.4%,P = 0.002) and poorly differentiated HCC(4.7% vs 0%,P < 0.001) compared to the NASH-HCC group.A trend of poorer recurrence free survival at 5 years was seen in HCV-HCC patients compared to NASH-HCC who underwent a Liver transplantation(P = 0.11).CONCLUSION:Patients transplanted for NASH-HCC appear to have less aggressive tumour features compared to those with HCV-HCC,which likely in part accounts for their improved recurrence free survival. | Roberto Hernandez-Alejandro Kris P Croome Martin Drage Nathalie Sela Jeremy Parfitt Natasha Chandok Paul Marotta Cheryl Dale William Wall Douglas Quan | 2012 | World Journal of Gastroenterology2012，18，31： | 5 |
| 4 | Building services engineering - the invisible architecture 显示文摘 | CROOME D J | 1990 | Building Serv Eng Res Technol1990，11，： | 2 |
| 5 | Effective selection of filter dust collectors 显示文摘 | Croom M L | 1993 | Chemical Engineering1993，100，7： | 1 |
| 6 | The X-31 Aircraft:Advances in Aircraft Agility and Performance显示文摘 | Alcorn C W Croom M A Francis M S | | 0，，： | 1 |
| 7 | Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutane- ous insulin infusion显示文摘 | Moyes V Driver R Croom A | 2006 | Diabet Med2006，23，2： | 1 |
| 8 | Effects of methionine hydroxy analog on milk secretion and ruminal and blood variables of dairy cows fed a low fiber diet显示文摘 | Ray S R Croom W J Rakes A H | 1983 | J Dairy Sci1983，66，： | 1 |
| 9 | Spotlight on the pharmaeoeconomics of escitalopram in depression显示文摘 | Croom KF Plosker GL | | 0，，： | 1 |
| 10 | Microa- rchitecture and spatial relationship between bacteria and ileal, cecal, and colonic epithelium in chicks fed a direct-fed microbial, PrimaLac, and salinomycin 显示文摘 | Chichlowski M Croom W J Edens F W | 2007 | Poultry Science2007，86，6： | 1 |
| 11 | Design of the ARES mars air-plane and mission architecture 显示文摘 | BRAUN R D WRIGHT H S CROOM M A LEVINE J S | 2006 | Journal of Spacecraftand Rockets2006，43，2： | 1 |
| 12 | Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutane- ous insulin infusion显示文摘 | Moyes V Driver R Croom A | 2006 | Diabet Med2006，23，2： | 1 |
| 13 | Mirtazapine: a review of its use in major depression and other psychiatric disorders显示文摘 | Croom KF Perry CM Plosker GL | 2009 | CNS Drugs2009，23，5： | 1 |
| 14 | Valsartan: a review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction显示文摘 | Croom KF Keating GM | 2004 | Am J Cardiovasc Drugs2004，4，6： | 1 |
| 15 | Re-investigating Business Excellence:Values,Measures and a Framework显示文摘 | LU D BETTS A CROOM S | 2011 | Total Quality Management & Business Excellence2011，22，12： | 1 |
| 16 | The impact of web-based procurement on the management of operating resources supply显示文摘 | Croom S R | 2000 | The Journal of Supply Chain Management2000，36，1： | 1 |
| 17 | The prediction of 'controlled' uterine rupture by the use of intrauterine pressure catheters显示文摘 | Devoe LD Croom CS Youssef AA | 1992 | Obstet Gynecol1992，80，4： | 1 |
| 18 | Insulin allergy m a pa- tient with Type 2 diabetes successfully treated with continu- ous subcutaneous insulin infusion 显示文摘 | Moyes V Driver R Croom A | 2006 | Diabet Med2006，23，2： | 1 |
| 19 | Supply Chain Management:an analytical framework for critical literature review显示文摘 | SIMON CROOM | 2000 | Purchasing & Supply Management2000，，6： | 1 |
| 20 | The global account management study显示文摘 | Wilson K J Millman T Croom S and Weilbaker D C | 2000 | The Journal of Selling and Major Account Management2000，2，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员